rotenone has been researched along with Chronic Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Li, H; Li, Z; Shen, L; Sun, B; Yang, J; Zhang, J; Zhang, N | 1 |
| Jimenez-Del-Rio, M; Quintero-Espinosa, DA; Velez-Pardo, C | 1 |
| Berger, JP; Constable, R; Di Natale, M; Diwakarla, S; Finkelstein, DI; Furness, JB; Kauhausen, J; Lee, S; McQuade, RM; Parish, CL; Ringuet, MT; Singleton, LM; Wu, H | 1 |
| Chowdhury, NR; Dorieux, FWC; Fagotti, J; Ilkiw, JL; Lima, MMS; Louzada, FM; Middleton, B; Noseda, ACD; Pennings, JLA; Rodrigues, LS; Scarante, FF; Skene, DJ; Swann, JR; Targa, ADS; van der Veen, DR | 1 |
| Boyd, J; Han, A | 1 |
| Feng, L; Huang, R; Jiang, C; Ke, W; Liu, Y; Pei, Y; Wu, D | 1 |
| Arnold, B; Berman, SB; Cassady, SJ; VanLaar, VS | 1 |
| Li, YL; Liu, J; Pipinos, II; Tu, H; Zhang, L; Zhu, Z | 1 |
| Champy, P; Féger, J; Hirsch, EC; Höglinger, GU; Michel, PP; Oertel, WH; Parain, K; Prigent, A; Ruberg, M | 1 |
| Archer, SL; Michelakis, E; Nelson, DP; Reeve, HL; Weir, EK | 1 |
1 review(s) available for rotenone and Chronic Disease
| Article | Year |
|---|---|
Deguelin and Its Role in Chronic Diseases.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Chronic Disease; Disease Models, Animal; Drug Discovery; Electron Transport Complex I; Enzyme Inhibitors; Humans; Molecular Structure; Parkinson Disease, Secondary; Phytotherapy; Plants, Medicinal; Risk Factors; Rotenone; Signal Transduction | 2016 |
9 other study(ies) available for rotenone and Chronic Disease
| Article | Year |
|---|---|
Comparison of the effect of rotenone and 1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine on inducing chronic Parkinson's disease in mouse models.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Avoidance Learning; Blotting, Western; Chronic Disease; Disease Models, Animal; DNA-Binding Proteins; Dopaminergic Neurons; Glial Fibrillary Acidic Protein; Humans; Immunohistochemistry; Mice, Inbred C57BL; Motor Activity; Nerve Tissue Proteins; Parkinson Disease, Secondary; Rotenone; Substantia Nigra; Tyrosine 3-Monooxygenase | 2022 |
High Yield of Functional Dopamine-like Neurons Obtained in NeuroForsk 2.0 Medium to Study Acute and Chronic Rotenone Effects on Oxidative Stress, Autophagy, and Apoptosis.
Topics: Apoptosis; Autophagy; Caspase 3; Chronic Disease; Dopamine; Dopaminergic Neurons; Humans; Hydrogen Peroxide; Oxidative Stress; Parkinson Disease; Rotenone | 2023 |
The association of enteric neuropathy with gut phenotypes in acute and progressive models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acute Disease; Animals; Cell Count; Chronic Disease; Colon; Disease Models, Animal; Feces; Ganglia; Gastrointestinal Tract; Intestinal Pseudo-Obstruction; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Nitric Oxide Synthase Type I; Oxidopamine; Parkinson Disease; Phenotype; Rotenone | 2021 |
Chronic sleep restriction in the rotenone Parkinson's disease model in rats reveals peripheral early-phase biomarkers.
Topics: Amino Acids, Branched-Chain; Animals; Area Under Curve; Biomarkers; Chromatography, High Pressure Liquid; Chronic Disease; Discriminant Analysis; Disease Models, Animal; Least-Squares Analysis; Male; Mass Spectrometry; Metabolome; Parkinson Disease; Rats; Rats, Wistar; ROC Curve; Rotenone; Sleep Wake Disorders | 2019 |
Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model.
Topics: Animals; Chronic Disease; Disease Models, Animal; Gene Expression Regulation; Gene Transfer Techniques; Genes, Reporter; Genetic Therapy; Genetic Vectors; Glial Cell Line-Derived Neurotrophic Factor; Green Fluorescent Proteins; Lactoferrin; Male; Nanoparticles; Neurotoxins; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Rotenone; Treatment Outcome; Uncoupling Agents | 2010 |
Integrating multiple aspects of mitochondrial dynamics in neurons: age-related differences and dynamic changes in a chronic rotenone model.
Topics: Aging; Animals; Cells, Cultured; Chronic Disease; Mitochondria; Mitochondrial Diseases; Models, Biological; Neurons; Parkinson Disease; Rats; Rotenone; Substantia Nigra; Uncoupling Agents | 2011 |
Mitochondria-derived superoxide and voltage-gated sodium channels in baroreceptor neurons from chronic heart-failure rats.
Topics: Action Potentials; Animals; Antimycin A; Biophysics; Bridged Bicyclo Compounds, Heterocyclic; Chronic Disease; Disease Models, Animal; Electric Stimulation; Enzyme Inhibitors; Gene Expression Regulation; Heart Failure; Hemodynamics; Humans; Lectins; Male; Mitochondria; Multienzyme Complexes; NADH Dehydrogenase; NAV1.7 Voltage-Gated Sodium Channel; Nodose Ganglion; Patch-Clamp Techniques; Phenanthridines; Pressoreceptors; Rats; Rats, Sprague-Dawley; Rotenone; Sodium Channel Blockers; Sodium Channels; Spectrophotometry; Succinate Dehydrogenase; Superoxide Dismutase; Tetrodotoxin; Transfection | 2012 |
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats.
Topics: Animals; Behavior, Animal; Cell Count; Choline O-Acetyltransferase; Chronic Disease; Corpus Striatum; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Drug Administration Schedule; Electron Transport Complex I; Enzyme Inhibitors; Inclusion Bodies; Infusions, Intravenous; Locus Coeruleus; Male; Mesencephalon; Motor Activity; Movement Disorders; NADH, NADPH Oxidoreductases; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroglia; Neurons; Pesticides; Phosphoproteins; Rats; Rats, Inbred Lew; Rotenone; Serotonin; Substantia Nigra; Time; Tyrosine 3-Monooxygenase | 2003 |
Alterations in a redox oxygen sensing mechanism in chronic hypoxia.
Topics: Animals; Blood Pressure; Blotting, Western; Chronic Disease; Electrophysiology; Glutathione; Hypoxia; Ion Channel Gating; Luminescent Measurements; Lung; Male; Oxidation-Reduction; Oxygen Consumption; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Rotenone | 2001 |